Total Payments
$3,811
2024 Payments
$367.19
Companies
29
Transactions
262
Medicare Patients
1,477
Medicare Billing
$129,026
Payment Breakdown by Category
Food & Beverage$3,761 (98.7%)
Education$50.20 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,761 | 260 | 98.7% |
| Education | $50.20 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,152 | 77 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $619.18 | 31 | $0 (2024) |
| Allergan Inc. | $275.07 | 22 | $0 (2018) |
| Celgene Corporation | $253.07 | 22 | $0 (2023) |
| Janssen Biotech, Inc. | $242.45 | 22 | $0 (2024) |
| PFIZER INC. | $213.96 | 19 | $0 (2022) |
| UCB, Inc. | $140.13 | 9 | $0 (2020) |
| Merck Sharp & Dohme LLC | $100.96 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $94.82 | 7 | $0 (2019) |
| Covidien LP | $75.02 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $367.19 | 20 | ABBVIE INC. ($119.78) |
| 2023 | $401.00 | 31 | Celgene Corporation ($166.33) |
| 2022 | $396.46 | 25 | ABBVIE INC. ($149.50) |
| 2021 | $187.67 | 13 | AbbVie Inc. ($112.13) |
| 2020 | $290.14 | 17 | AbbVie Inc. ($169.55) |
| 2019 | $833.26 | 63 | AbbVie, Inc. ($187.52) |
| 2018 | $643.36 | 40 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($205.17) |
| 2017 | $692.09 | 53 | Allergan Inc. ($264.36) |
All Payment Transactions
262 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.65 | General |
| Category: GI | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $25.48 | General |
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Immunology | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Biosimilars | ||||||
| 07/03/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Immunology | ||||||
| 06/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Gastroenterology | ||||||
| 06/03/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Obesity | ||||||
| 05/02/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Gastroenterology | ||||||
| 04/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: IMMUNOLOGY | ||||||
| 04/02/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/31/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Gastroenterology | ||||||
| 12/13/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/16/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Immunology | ||||||
| 10/26/2023 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Biosimilars | ||||||
| 10/25/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/21/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $5.29 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 378 | 416 | $162,009 | $39,591 |
| 2022 | 13 | 385 | 422 | $127,596 | $32,215 |
| 2021 | 15 | 458 | 498 | $124,117 | $36,976 |
| 2020 | 9 | 256 | 337 | $69,075 | $20,244 |
Total Patients
1,477
Total Services
1,673
Medicare Billing
$129,026
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 63 | 65 | $52,520 | $12,864 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 75 | $15,375 | $6,871 | 44.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 63 | 64 | $45,312 | $4,738 | 10.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 37 | $8,781 | $3,551 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 43 | $6,235 | $2,696 | 43.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 25 | 25 | $11,675 | $1,953 | 16.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 31 | $3,875 | $1,828 | 47.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 11 | 11 | $6,237 | $1,765 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,679 | $1,633 | 44.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $7,840 | $1,436 | 18.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 17 | $255.00 | $142.80 | 56.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 14 | 15 | $225.00 | $114.15 | 50.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 53 | 53 | $42,824 | $9,854 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 99 | $13,935 | $5,748 | 41.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 36 | $8,316 | $3,423 | 41.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 40 | 40 | $28,320 | $2,738 | 9.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 43 | $5,375 | $2,353 | 43.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 27 | 27 | $12,609 | $1,966 | 15.6% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2022 | 23 | 23 | $2,875 | $1,725 | 60.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 17 | 18 | $7,056 | $1,522 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 14 | $2,720 | $1,287 | 47.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,136 | $858.08 | 40.2% |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | Office | 2022 | 23 | 23 | $920.00 | $575.00 | 62.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 13 | 14 | $210.00 | $107.42 | 51.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 18 | 20 | $300.00 | $59.28 | 19.8% |
About Dr. William Outlaw, MD
Dr. William Outlaw, MD is a Gastroenterology healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346353315.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Outlaw, MD has received a total of $3,811 in payments from pharmaceutical and medical device companies, with $367.19 received in 2024. These payments were reported across 262 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,761).
As a Medicare-enrolled provider, Outlaw has provided services to 1,477 Medicare beneficiaries, totaling 1,673 services with total Medicare billing of $129,026. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Greensboro, NC
- Active Since 08/16/2006
- Last Updated 04/22/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1346353315
Products in Payments
- XIFAXAN (Drug) $481.22
- Mavyret (Drug) $259.85
- VIBERZI (Drug) $234.82
- ZEPOSIA (Drug) $231.50
- MAVYRET (Drug) $221.72
- XELJANZ (Drug) $213.96
- STELARA (Biological) $213.22
- LINZESS (Drug) $203.40
- Humira (Biological) $173.36
- Cimzia (Drug) $140.13
- DIFICID (Drug) $100.96
- RINVOQ (Biological) $98.32
- Creon (Drug) $92.82
- DUPIXENT (Biological) $87.33
- ZENPEP (Drug) $72.91
- Entyvio (Biological) $67.27
- Trulance (Drug) $52.57
- HUMIRA (Biological) $49.77
- CREON (Drug) $49.53
- Amitiza (Drug) $46.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Greensboro
Dr. Patrick Hung, Md, MD
Gastroenterology — Payments: $40,240
Gastroenterology $40,240
Dr. Jyothi Mann, Md, MD
Gastroenterology — Payments: $31,505
Gastroenterology $31,505
Vincent Schooler, Md, MD
Gastroenterology — Payments: $4,224
Gastroenterology $4,224
Marc Magod, Md, MD
Gastroenterology — Payments: $4,164
Gastroenterology $4,164
Dr. Parag Brahmbhatt, M.d, M.D
Gastroenterology — Payments: $4,061
Gastroenterology $4,061
Dr. Claire Vreeland, D.o, D.O
Gastroenterology — Payments: $2,364
Gastroenterology $2,364